Masp-2 deficiency and the development of diabetic kidney disease in a mouse model of type 1 diabetes

被引：0
|
作者：
Holt, C. B. [1 ,2 ]
Halkjaer, L. [2 ,3 ]
Dudler, T. [4 ]
Schwaeble, W. J. [5 ]
Hansen, T. K. [1 ]
Thiel, S. [3 ]
Ostergaard, J. A. [1 ,6 ]
机构：
[1] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[2] Aarhus Univ, Dept Clin Med, Aarhus, Denmark
[3] Aarhus Univ, Dept Biomed, Aarhus, Denmark
[4] Omeros Corp, Dept Res, Seattle, WA USA
[5] Univ Leicester, Dept Infect Immun & Inflammat, Leicester, Leics, England
[6] Aarhus Univ Hosp, Dept Endocrinol & Internal Med, Aarhus, Denmark
来源：
DIABETOLOGIA | 2022年 / 65卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
792
引用
收藏
页码：S407 / S408
页数：2
相关论文
共 50 条
  • [1] MASP-2 deficiency does not prevent the progression of diabetic kidney disease in a mouse model of type 1 diabetes
    Brinck, Holt Charlotte
    Lene, Halkjaer
    Tom, Dudler
    Wilhelm, Schwaeble
    Krarup, Hansen Troels
    Steffen, Thiel
    Appel, Ostergaard Jakob
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 2024, 99 (04)
  • [2] Plasma levels of MASP-1 and MASP-2 are elevated in patients with type 1 diabetes
    Frauenknecht, V.
    Ajjan, R.
    Thiel, S.
    Schroeder, V.
    MOLECULAR IMMUNOLOGY, 2013, 56 (03) : 273 - 273
  • [3] Ficolin B in Diabetic Kidney Disease in a Mouse Model of Type 1 Diabetes
    Holt, Charlotte Berg
    Ostergaard, Jakob Appel
    Axelgaard, Esben
    Nielsen, Gitte Krogh
    Endo, Yuichi
    Thiel, Steffen
    Hansen, Troels Krarup
    MEDIATORS OF INFLAMMATION, 2015, 2015
  • [4] A Novel Type 2 Diabetes Mouse Model of Combined Diabetic Kidney Disease and Atherosclerosis
    Bornfeldt, Karin E.
    Kramer, Farah
    Batorsky, Anna
    Choi, Jinkuk
    Hudkins, Kelly L.
    Tontonoz, Peter
    Alpers, Charles E.
    Kanter, Jenny E.
    AMERICAN JOURNAL OF PATHOLOGY, 2018, 188 (02): : 343 - 352
  • [5] Transcriptomic analysis of diabetic kidney disease and neuropathy in mouse models of type 1 and type 2 diabetes
    Elzinga, Sarah E.
    Eid, Stephanie A.
    McGregor, Brett A.
    Jang, Dae-Gyu
    Hinder, Lucy M.
    Dauch, Jacqueline R.
    Hayes, John M.
    Zhang, Hongyu
    Guo, Kai
    Pennathur, Subramaniam
    Kretzler, Matthias
    Brosius, Frank C.
    Koubek, Emily J.
    Feldman, Eva L.
    Hur, Junguk
    DISEASE MODELS & MECHANISMS, 2023, 16 (10)
  • [6] C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes
    F. Liu
    H. Y. Chen
    X. R. Huang
    A. C. K. Chung
    L. Zhou
    P. Fu
    A. J. Szalai
    H. Y. Lan
    Diabetologia, 2011, 54 : 2713 - 2723
  • [7] C-reactive protein promotes diabetic kidney disease in a mouse model of type 1 diabetes
    Liu, F.
    Chen, H. Y.
    Huang, X. R.
    Chung, A. C. K.
    Zhou, L.
    Fu, P.
    Szalai, A. J.
    Lan, H. Y.
    DIABETOLOGIA, 2011, 54 (10) : 2713 - 2723
  • [8] Diabetic kidney disease in type 1 diabetes: challenges and differences from type 2 diabetes
    Popovic, Djordje S.
    Patoulias, Dimitrios
    Gnudi, Luigi
    Mantzoros, Christos S.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2024, 151
  • [9] Mannan-Binding Lectin in Diabetic Kidney Disease: The Impact of Mouse Genetics in a Type 1 Diabetes Model
    Ostergaard, Jakob Appel
    Bjerre, Mette
    RamachandraRao, Satish Posettihalli
    Sharma, Kumar
    Nyengaard, Jens Randel
    Hansen, Troels Krarup
    Thiel, Steffen
    Flyvbjerg, Allan
    EXPERIMENTAL DIABETES RESEARCH, 2012,
  • [10] CXCL5 Inhibition Attenuates Diabetic Kidney Disease in a Mouse Model of Type 2 Diabetes Mellitus
    Chang, Ting-Ting
    Chen, Ching
    Chen, Jaw-Wen
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 106 - 106
12345